Citations

Citations to this article as recorded by  

• Increased Asialoglycoprotein Receptor 1 Level in Granulosa Cell as a Potential Biomarker for Polycystic Ovary Syndrome
  Xitong Liu, Rongxia Xie, Yang Cai, Hui Lan, Jing Mu, Chen Zhang, Bo Li
  Reproductive Sciences.2026;[Epub]     CrossRef
• Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin
  Jing-Ming Wang, Li-Yan Jiang, Yu-Ting Deng, Jiao-Yang Li, Heng Sun, Li Ran, Xinhua Xiao
  BMJ Open Diabetes Research & Care.2026; 14(1): e005638.     CrossRef
• Association Analysis of the Circulating Proteome With Sarcopenia‐Related Traits Reveals Potential Drug Targets for Sarcopenia
  Simin Wen, Siqi Xu, Xizeng Zong, Shifeng Wen, Wende Xiao, Weipeng Zheng, Han Cen, Zhaohua Zhu, Jingyu Xie, Yan Zhang, Changhai Ding, Guangfeng Ruan
  Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
• Serum Soluble Asialoglycoprotein Receptor 1: A Potential Predictor Marker Linked to Type 2 Diabetes Mellitus, Demonstrating Positive Correlation With High Sensitive C-Reactive Protein
  Haifeng Zhu, Ziyi Zhong, Gaonian Zhao, Yuan Cao, Wei Liu, Yawen Guo, Jing Jin
  Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 663.     CrossRef
• Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations
  Pik Fang Kho, Neil Wary, Daniela Zanetti, Fahim Abbasi, Joshua W. Knowles, Daniel J. Panyard, Katie T. Watson, Laurel Stell, Laura C. Lazzeroni, Stefan Gustafsson, Lars Lind, John R. Petrie, Themistocles L. Assimes
  Metabolism.2025; 169: 156263.     CrossRef
• Causal Relationship Between Serum Zinc Levels and Diabetic Kidney Disease (DKD): A Plasma Proteomics Mediation Study
  Chunbo Zhao, Tingting Pan, Wei Liu, Fanqian Cheng, Xiaoxuan Zhao, Shuxin Yu, Yi Yang, Ran Zhang, Weixia Sun
  Biological Trace Element Research.2025;[Epub]     CrossRef
• Triglyceride-glucose index and triglyceride-to-high-density lipoprotein cholesterol ratio as novel predictors of acute kidney injury: an analysis of the UK biobank
  Fangfang Zhou, Yuanyuan Wang, Youjun Xu, Lailiang Wang, Jinxia Ge, Qun Luo, Hongpeng Sun
  Renal Failure.2025;[Epub]     CrossRef
• Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study
  Valerie K. Sullivan, Jingsha Chen, Lawrence J. Appel, Sarah Schrauben, Ana C. Ricardo, Panduranga Rao, Mirela Dobre, Nishigandha Pradhan, Jing Chen, Jiang He, Hernan Rincon-Choles, Paul L. Kimmel, Casey M. Rebholz
  Clinical Journal of the American Society of Nephrology.2025;[Epub]     CrossRef
• Experimental cell models of insulin resistance: overview and appraisal
  Ying Yang, Ting-ting Wang, Hu-ai Xie, Ping Ping Hu, Pan Li
  Frontiers in Endocrinology.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Hydroalcoholic extract of Benincasa hispida (Thunb.) Cogn. reinstates renal structural and functional dynamics compromised in diabetic mice: molecular insights through integration of transcriptomics and proteomics
  Nivedita Singh, Anuradha Kesharwani, Rahul Laxman Gajbhiye, Harsha Sankar Sreenikethanam Hari, Ruthrotha Selvi Bharathavikru, Velayutham Ravichandiran, Vipan Kumar Parihar
  Journal of Ethnopharmacology.2026; 362: 121132.     CrossRef
• Dietary and nutritional interventions for human diseases: their modulatory effects on ferroptosis
  Shiqiong Huang, Ji Sun, Chaozan Shen, Gefei He
  Food & Function.2025; 16(4): 1186.     CrossRef
• Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes
  Imari Mimura, Zhuo Chen, Rama Natarajan
  Kidney International.2025; 107(3): 434.     CrossRef
• Protective role of sulforaphane in lipid metabolism-related diseases
  Lingfeng Zhao, Jiahuan Li, Yiping Dang, David Fisher, Nguyen Thi Thu Hien, Erkin Musabaev, Khrystyna Pronyuk, Lei Zhao
  Molecular Biology Reports.2025;[Epub]     CrossRef
• Histone deacetylases and their inhibitors in kidney diseases
  Yue Zheng, Tie-Ning Zhang, Peng-Hui Hao, Ni Yang, Yue Du
  Molecular Therapy.2025; 33(8): 3485.     CrossRef
• Investigating potential targets of Wulingsan in diabetic nephropathy through network pharmacology and experimental validation
  Xicheng Hu, Zhen Wang, Liyan Zhang
  Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
• Chidamide, a novel histone deacetylase inhibitor, alleviates renal fibrosis by suppressing the PI3K/AKT signaling pathway
  Yumei Liu, Liwen Mao, Yanbing Tang, Xiaowen Huang, Cunjin Su, Ye Zhu, Qianqian Duan, Kai Song, Jie Pan, Zhanhong Hu
  Biochemical Pharmacology.2025; 240: 117098.     CrossRef
• Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases
  Sunyoung Jang, Nayun Choi, Jong Hoon Park, Kyung Hyun Yoo
  BMB Reports.2025; 58(8): 313.     CrossRef
• Acetylation in renal physiology and pathophysiology
  Jian-Yu Zhang, Jun Wu, Zi-Han Chen, Shi-Yue Liu, Ping Li, Dan-Qian Chen
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Sulforaphane from broccoli, an epigenetic modulator in cancer cells
  Soayébo Dabre, Abdou Azaque Zoure, Lassina Barro, Jeanne d’Arc Wendmintiri Kabre, Mousso Savadogo, Aida Dje Traore, Florencia Djigma, Jacques Simpore
  Discover Oncology.2025;[Epub]     CrossRef
• Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance
  Minlong Wei, Jinyun Lin, Yi Zeng, Xiaojuan Wang, Jialu Wen, Jing Wang, Wei Zou, Kang Tu, Menghua Liu, Juan Li
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Epigenetic repurposing of carbohydrate metabolic inhibitors for insulin resistance: targeting DNMT1 and HDAC3 for β-cell restoration
  Muhammad Javid Iqbal, Luis A. Salazar
  Frontiers in Epigenetics and Epigenomics.2025;[Epub]     CrossRef
• Glucosinolates Hydrolysis Products: Promising Bioactives for the Prevention of Diabetes
  Rohini Bhat, Sugandh Saxena, Manu Khajuria, Dhiraj Vyas
  Molecular Nutrition & Food Research.2025;[Epub]     CrossRef
• Pharmacological Modulation of the Nrf2–Keap1 Pathway in Diabetes: Mechanisms, Therapeutic Advances, and Future Directions
  Amar Saxena, Shrestha Saxena, Yash Saxena, Ashita Jain, Rama Chaudhary, Pooja Bharti, Shivdeep Mishra, Chandrabhan Singh, Abhishek Kumar, Ankit Kumar, Sanjeev Kumar
  Journal for Research in Applied Sciences and Biotechnology.2025; 4(5): 38.     CrossRef
• Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
  Tao Jiang, Yuhe Dong, Wanying Zhu, Tong Wu, Linyan Chen, Yuantong Cao, Xi Yu, Ye Peng, Ling Wang, Ying Xiao, Tian Zhong
  Critical Reviews in Food Science and Nutrition.2024; 64(31): 11543.     CrossRef
• Sulforaphane reduces adipose tissue fibrosis via promoting M2 macrophages polarization in HFD fed-mice
  Zhenzhen Zhang, Huali Chen, Cheng Pan, Rui Li, Wangsheng Zhao, Tianzeng Song
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(2): 119626.     CrossRef
• Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms
  Patrícia dos Santos Azeredo, Daping Fan, E. Angela Murphy, Wayne E. Carver
  Cells.2024; 13(5): 421.     CrossRef
• Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes
  Katarina Zeder, Edward D. Siew, Gabor Kovacs, Evan L. Brittain, Bradley A. Maron
  Nature Reviews Nephrology.2024; 20(11): 742.     CrossRef
• Role of Histone Modifications in Kidney Fibrosis
  Shengyu Pan, Tianhui Yuan, Yuqi Xia, Weimin Yu, Xiangjun Zhou, Fan Cheng
  Medicina.2024; 60(6): 888.     CrossRef
• Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation
  Yanan Wang, Xiaoyun He, Nan Cheng, Kunlun Huang
  Nutrients.2024; 16(12): 1877.     CrossRef
• Nonsurgical therapy for lumbar spinal stenosis caused by ligamentum flavum hypertrophy: A review
  Nan Fang, Zhigang Wang, Jiecheng Jiang, Aofei Yang, Tian Mao, Zitong Wang, Qian Chen
  Medicine.2024; 103(27): e38782.     CrossRef
• Sulforaphane alleviates renal fibrosis through dual regulation on mTOR-mediated autophagy pathway
  Di Zhang, Han Zhang, Shiqi Lv, Cheng Zhu, Shaomin Gong, Xixi Yu, Yulin Wang, Xinhui Huang, ShuangXin Yuan, Xiaoqiang Ding, Xiaoyan Zhang
  International Urology and Nephrology.2024; 57(4): 1277.     CrossRef
• Beneficial role of broccoli and its active ingredient, sulforaphane in the treatment of diabetes
  Aminu Mohammed, Hafsat Abdullahi Mohammed
  Phytomedicine Plus.2023; 3(2): 100431.     CrossRef
• The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
  Christodoula Kourtidou, Konstantinos Tziomalos
  International Journal of Molecular Sciences.2023; 24(6): 6007.     CrossRef
• Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
  Da-Wei Lin, Yung-Chien Hsu, Cheng-Chih Chang, Ching-Chuan Hsieh, Chun-Liang Lin
  International Journal of Molecular Sciences.2023; 24(7): 6053.     CrossRef
• Beneficial Effects of Sulforaphane on Diabetes and Its Complications via Both Nrf2-Dependent and Independent Mechanisms
  Minhyuk Kim, Joo Young Lee
  Food Supplements and Biomaterials for Health.2023;[Epub]     CrossRef
• Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis
  Elisa B. Monteiro, Matheus Ajackson, Milena B. Stockler-Pinto, Fitsum Guebre-Egziabher, Julio B. Daleprane, Christophe O. Soulage
  Life Sciences.2023; 322: 121664.     CrossRef
• Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway
  Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
  Chemico-Biological Interactions.2023; 382: 110559.     CrossRef
• Sulforaphane: A nutraceutical against diabetes-related complications
  Sinenhlanhla X.H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Marakiya T. Moetlediwa, Ndivhuwo Muvhulawa, Sonia Silvestri, Patrick Orlando, Bongani B. Nkambule, Christo J.F. Muller, Duduzile Ndwandwe, Albertus K. Basson, Luca Tiano, Phiwayinkosi V. Dludla
  Pharmacological Research.2023; 196: 106918.     CrossRef
• Nrf2/HO-1 as a therapeutic target in renal fibrosis
  Emad H.M. Hassanein, Islam M. Ibrahim, Esraa K. Abd-alhameed, Zeina W. Sharawi, Fatima A. Jaber, Hanan S. Althagafy
  Life Sciences.2023; 334: 122209.     CrossRef
• A mechanistic overview of sulforaphane and its derivatives application in diabetes and its complications
  Neda Mohamadi, Vafa Baradaran Rahimi, Mohammad Reza Fadaei, Fatemeh Sharifi, Vahid Reza Askari
  Inflammopharmacology.2023; 31(6): 2885.     CrossRef
• The HDAC2/SP1/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease
  Zongji Zheng, Shuting Zhang, Jiaqi Chen, Meina Zou, Yanlin Yang, Wen Lu, Shijing Ren, Xiangyu Wang, Wenhui Dong, Zikun Zhang, Ling Wang, Meiping Guan, Gladys L.Y. Cheing, Yaoming Xue, Yijie Jia
  Clinical Science.2022; 136(3): 223.     CrossRef
• BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
  Yawen Xiao, Dan Liang, Zhiyang Li, Zhaowei Feng, Zhiping Yuan, Fan Zhang, Yuanyuan Wang, Yuxia Zhou, Mingjun Shi, Lingling Liu, Ying Xiao, Bing Guo
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation
  Chun Ouyang, Lei Huang, Xiaoqiang Ye, Mingming Ren, Zhen Han
  Experimental and Clinical Endocrinology & Diabetes.2022; 130(10): 660.     CrossRef
• Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
  Jialu Li, Chao Yu, Fengchen Shen, Binbin Cui, Na Liu, Shougang Zhuang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
  Jiayu Wang, Jiaxing Li, Xin Zhang, Min Zhang, Xiaopeng Hu, Hang Yin
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• The improvement of sulforaphane in type 2 diabetes mellitus (T2DM) and related complications: A review
  Mengjiao Wang, Min Chen, Rui Guo, Yangyang Ding, Haihui Zhang, Yuanqing He
  Trends in Food Science & Technology.2022; 129: 397.     CrossRef
• Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
  Hao Yan, Jiangxin Xu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He
  Biomedicine & Pharmacotherapy.2021; 143: 112115.     CrossRef